Formulations

Details for Australian Patent Application No. 2005227421 (hide)

Owner Pharma Mar S.A., Sociedad Unipersonal

Inventors Tobio Barreira, Maria; Beijnen, Jacob Hendrik; Nuijen, Bastiaan; Calvo Salve, Pilar

Agent Griffith Hack

Pub. Number AU-B-2005227421

Priority 60/623,813 29.10.04 US

Filing date 28 October 2005

Wipo publication date 18 May 2006

Acceptance publication date 28 June 2007

International Classifications

A61K 31/4995 (2006.01) - Pyrazines or piperazines forming part of bridged ring systems

A61K 31/7016 (2006.01) - Disaccharides, e.g. lactose, lactulose

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

17 November 2005 Complete Application Filed

  Priority application(s): 60/623,813 29.10.04 US

18 May 2006 Application Open to Public Inspection

  Published as AU-B-2005227421

28 June 2007 Application Accepted

  Published as AU-B-2005227421

25 October 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005227422-Medidebt

2005227420-Method and compositions for altering cell function